Australian Doctor 13th Sept Issue | Page 6

6 NEWS

6 NEWS

13 SEPTEMBER 2024 ausdoc . com . au

Is semaglutide a suicide risk ?

Mohana Basu RESEARCHERS have called for an
safety signal , said the multinational research team .
suicidality were excluded from the pivotal trials of semaglutide .
antidepressants or benzodiazepines with semaglutide ( odds ratio 4.45 and
urgent assessment of a possible link
The finding remained statistically
This led them to interrogate the
4.07 , respectively ) compared with all
between semaglutide and suicidal-
significant when semaglutide was
WHO ’ s pharmacovigilance archive ,
medications in the database .
ity based on a study of a WHO adverse
compared specifically with dapagli-
which contains more than 28 million
“ Based on these findings , we
event database .
flozin , metformin or orlistat .
reports from 140 countries .
believe that a precaution of use in
Their study , published in JAMA
Both UK and US regulators have
They identified 107 unique cases
patients with psychiatric disorders or
Network Open , found a higher report-
launched investigations into sema-
of suicidal or self-harm-related
psychological lability could be added
ing rate for suicidal ideation with
glutide ’ s possible link with suicidal
adverse drug reports associated with
in the semaglutide package insert ,”
semaglutide compared with other medications in the database ( odds ratio 1.45 ).
Liraglutide , another GLP-1 receptor agonist , did not raise the same
ideation , although the preliminary US findings found no evidence they were connected .
The study authors said patients with a history of depression or
semaglutide ( 0.35 % of total semaglutide-related reports ).
The risk of reported suicidal ideation was substantially greater in patients co-prescribed
the authors said . If this news story has raised issues for you , call Lifeline on 13 11 14 or contact your local doctors ’ health service . JAMA Netw Open 2024 ; 20 Aug .

‘ Too junior ’ to manage toddler

PAGE 2
failing to examine
Noah himself or to review his
records prior to his discharge .
He had earlier eyeballed
Noah while passing his cubicle
, “ but this was no more
than a glance and was an
inadequate basis for him to
form an opinion about Noah ’ s
clinical condition at the time
or , indeed , sometime later
when discussing the plan for
discharge ”.
The coroner rejected a
claim by the hospital ’ s clinical
director of emergency
services , Dr Johann De Witt
Oosthuizen , that “ having
someone in the second-incharge
shift is better than
having no-one in the shift ”.
“ Because , in Noah ’ s case ,
the consequence of having
an underqualified doctor in a
senior role meant that a senior
review did not take place
as a matter of course ,” Ms
Lorenz wrote .
The inquest was told that
the hospital often had to fill
shifts through locum agencies
at short notice . While it
preferred to use doctors who
had previously been at the
hospital , it would accept less
experienced clinicians , particularly
at late notice .
“ There is an important
distinction to be made
between a locum with high
qualifications and a more
junior locum hired to fill
a senior role ,” the coroner
continued .
“ Accordingly , it is vital
that a senior in charge doctor
in an ED makes reasonable
inquiries with respect
to new locums , no matter
what the role , to gauge
some sense of the locum ’ s
actual capabilities regardless
of the assigned role for that
person .”
The coroner acknowledged
that the hospital ’ s
ED orientation booklet now
emphasised that new locums
were expected to discuss
their first five patients with
the senior doctor in charge .
The findings have been
provided to AHPRA .